Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX

Klee Justin B. sold 30,464 Amylyx Pharmaceuticals, Inc. shares (Form 4)

Traded Sep 10, 2026 · Filed Sep 14, 2026

On Sep 10, 2026, Klee Justin B. (Director, Co-Chief Executive Officer) sold 30,464 Amylyx Pharmaceuticals, Inc. shares at an average US$32.18 for US$980K, leaving 3,613,056 shares. Filed Sep 14, 2026 (Form 4).

Sold
30,464 shares
Price
US$32.18 average (US$32.13 to US$33.16)
Value
US$980K
Holding after
3,613,056 shares
Trading plan
No
Role
Director, Co-Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 10, 2026Common StockSale29,025US$32.133,614,495Direct
Sep 10, 2026Common StockSale1,439US$33.163,613,056Direct

Source

View original at SEC

Related